Table of Contents Table of Contents
Previous Page  127 / 1631 Next Page
Information
Show Menu
Previous Page 127 / 1631 Next Page
Page Background

Eligibility and treatment schema

Eligibility

Disease: rel/ref HL

Stage: early/early (dx/relapse)

Tx: <6c chemotherapy

RT: none or relapse out of field

Exclusion

:

Advanced stage (dx

or

relapse

Tx: 6c chemotherapy

In-field relapse

B symptoms or bulky disease

Pembrolizumab 200 mg q3w x4

PET-Sim

PET-Sim

(within 14-21d)

DS 1-3

DS 4-5 w/o new sites

Responding on CT

New lesions

POD on CT

30 Gy

Biopsy

Off Study

36-40 Gy

30 Gy

Neg

Pos

ISRT

EOT PET

4-6w